IDENTIFICATION OF RELATIONSHIP PAINFUL ERECTION WITH DEPRESSION AND ANXIETY IN PATIENTS WITH PEYRONIE'S DISEASE
https://doi.org/10.21886/2308-6424-2016-0-1-32-37
Abstract
The prevalence of Peyronie's disease is about 10% of the male population of 100 thousand. Since, according to the polls 77% of men suffering from this disease, the deterioration of the quality of life in general, which is connected not only with the existing deviation of the penis, causing an aesthetic dissatisfaction and technical difficulties during coitus, but also the associated erectile dysfunction, according to a 25% -80% of cases. The object of the study were 24 patients with Peyronie's disease. The patients were divided into 2 groups according to the degree painful erections. Subsequently, all patients were survey using the hospital anxiety and depression questionnaire, including two sub-scales of anxiety (A) and depression (D).When interpreting the data, consider the total figure for each subscale (A and D), while the values of the area allocated 3: 0-7 points norm; 8-10 subclinical expressed anxiety / depression; 11 points or more clinically severe anxiety / depression. Group 1 patients with an average intensity of pain during an erection, there was subclinical anxiety and depression. A group 2 patients with an average intensity of pain during an erection, clinically severe anxiety and depression. Patients with Peyronie's disease revealed depression and anxiety, having a correlation dependence of the degree of pain during erection. Severe depression and anxiety, can be the cause of psychogenic erectile dysfunction.
About the Authors
M. K. Alchinbayev
Scientific Centre of Urology named after B.U.Dzharbussynov
Kazakhstan
Almaty city
Kazakhstan
Almaty city
M. A. Makazhanov
Scientific Centre of Urology named after B.U.Dzharbussynov
Kazakhstan
Almaty city
Kazakhstan
Almaty city
I. T. Muhamedzhan
Scientific Centre of Urology named after B.U.Dzharbussynov
Kazakhstan
Almaty city
Kazakhstan
Almaty city
K. Zh. Maskutov
Scientific Centre of Urology named after B.U.Dzharbussynov
Kazakhstan
Almaty city
Kazakhstan
Almaty city
References
1. HellstromW. History, epidemiology, and clinical presentation of Peyronies disease / Int. J. Impotence Res. 2003 - V.15,Suppl.5 - P.S91-S92.
2. Hellstrom W., Usta M. Surgical approaches for advanced Peyronie's disease patients / Int.J.Impotence Res- 2003-V. 15,Suppl.5-P. S121-124
3. La Pera G., Percatori E. et al Peyronies disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years.//Eur. Urol.-2001-V.40-p.525-530.
4. Liffel M.S. "Is there an immunogenetic basis for Peyronie's disease?" J Urol 1997; 157:295-297
5. Levine L.,Greenfield J. Establishing a standardized evaluation of the man with Peyronie's disease /Int.J.Impotence Res- 2003-V. 15,Suppl.5-P. S103-112.
6. Leopardi O.,Colombo F.,Frigo B.,Zucchi A.,Patelli E.,Collechia M.,et al. Immunohistochemical and quantative study of mast cells in La Peyronie's disease" Eur .Urol. 2000;37:176-82
7. Lue Т., Gelbard M. et al. Peyronie's disease / In : Erectile Dysfunction,Eds. A.Jardin, G.Wagner et al., 2000 London -P. 439-476.
8. Moreland R., Nehra A. Pathophisiology of Peyronie's disease / A. J. Impotence Res 2002 - V. 14 - P. 406-410.
9. Montorsi F. Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease / J. Urol (Baltimore) -2000-V/163. -P. 1704-1708.
10. Mulhall J., Thorn J., Lubrano T. et al. Basic fibroblast growth factor expression in Peyronie's disease. / J. Urol. (Baltimore) 2001 - V. 165 - P.419-423.
11. Pryor J., Ralph D. Clinical presentation of Peyronie;s disease / Int. J. Impotence Res. -2002 V. 14 - P 414-417
12. Sommer F. Epidemiology of Peyronie's disease / Int. J. Impotence res. - 2002 - V.14- P. 379-383.
13. Schultheiss D. et al. Congenital and acquired penile curvature treated with the Essed plication method / Eur. Urol.- 2000-V. 38-P. 167-171.
14. Tefekli A., Kandirali E. et al. Peyronie's disease in men under age 40: characteristics and outcome / International J. Impotence Res. -2001. V. 13 - P. 1823.
15. Tunuguntla H.S.G.R. Management of Peyroni’s disease // World J Urol-2001-V. 19-p. 244-250.
16. Usta M. Patient and partner satisfaction and long-term results after surgical treatment for Peyronie's disease / Urology-2003 V. 62 - P. 105-109.
17. Bartolomucci A., Leopardi R. Stress and Depression: Preclinical Research and Clinical Implications / A. Bartolomucci, R. Leopardi // PLoS ONE. 2009 - V.4-1.1 - e4265.
18. Baune B. Conceptual Challenges of a Tentative Model of Stress-Induced Depression / B. Baune // PLoS ONE. 2009 - V.4 -1.1 - e4266.
19. Branney P., White A. Big boys don't cry: Depression and men / P. Branney, A. White //Psychiatr. Treatment. 2008. - N14. - P.256-262.
20. M.Fava, A.J.Rush, J.E. Alpert, C.N. Carmin, G.K. Balasubramani et al. // Can. J. Psychiatry. 2006. - №51(13). - P.823-835.
Review
For citations:
Alchinbayev M.K., Makazhanov M.A., Muhamedzhan I.T., Maskutov K.Zh. IDENTIFICATION OF RELATIONSHIP PAINFUL ERECTION WITH DEPRESSION AND ANXIETY IN PATIENTS WITH PEYRONIE'S DISEASE. Urology Herald. 2016;(1):32-37. (In Russ.) https://doi.org/10.21886/2308-6424-2016-0-1-32-37
Views:
1386
Email this article 
